Guangdong Biolight Meditech Co., Ltd. (SHE:300246)

SHE:300246 Revenue

Guangdong Biolight Meditech had revenue of 242.99M CNY in the quarter ending March 31, 2026, a decrease of -1.91%. This brings the company's revenue in the last twelve months to 1.09B, up 4.73% year-over-year. In the year 2025, Guangdong Biolight Meditech had annual revenue of 1.10B with 3.29% growth.

• Revenue (ttm): 1.09B
• Revenue Growth: +4.73%
• P/S Ratio: 4.08
• Revenue / Employee: 816.97K
• Employees: 1,335
• Market Cap: 4.45B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.10B	34.91M	3.29%
Dec 31, 2024	1.06B	-133.52M	-11.18%
Dec 31, 2023	1.19B	10.30M	0.87%
Jan 1, 2023	1.18B	92.68M	8.49%
Jan 1, 2022	1.09B	-305.00M	-21.85%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error